- Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
-
Teng ML, Tan DJH, Ng CH, Huang DQ
- KMID: 2541429
- Clin Mol Hepatol.
- 2023 Apr;29(2):404-407.
- doi: 10.3350/cmh.2023.0069
-
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
-
Ng CH, Huang DQ, Nguyen MH
- KMID: 2534343
- Clin Mol Hepatol.
- 2022 Oct;28(4):790-801.
- doi: 10.3350/cmh.2022.0070
Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world’s adult population and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Global incidence and prevalence of nonalcoholic fatty liver disease
-
Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD
- KMID: 2539788
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S32-S42.
- doi: 10.3350/cmh.2022.0365
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males... -
- CITED
-
- Close
- SHARE
-
- Close
- Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
-
Teng PC, Huang DQ, Lin TY, Noureddin M, Yang JD
- KMID: 2538154
- Gut Liver.
- 2023 Jan;17(1):24-33.
- doi: 10.5009/gnl220357
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is a hepatic manifestation of insulin resistance, the core pathophysiology of diabetes.... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
-
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ
- KMID: 2534351
- Clin Mol Hepatol.
- 2022 Oct;28(4):864-875.
- doi: 10.3350/cmh.2022.0136
Background/Aims: Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
-
Ng CH, Chan KE, Chin YH, Zeng RW, Tsai PC, Lim WH, Tan DJH, Khoo CM, Goh LH, Ling ZJ, Kulkarni A, Mak LYL, Huang DQ, Chan M, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M
- KMID: 2531379
- Clin Mol Hepatol.
- 2022 Jul;28(3):565-574.
- doi: 10.3350/cmh.2022.0096
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted... -
- CITED
-
- Close
- SHARE
-
- Close
